PharmaShots | Incisive News in 3 Shots

Subscribe Now

First Patient

Innovent Reports First Patient Dosing in P-II Trial of IBI302 for Neovascular Age-Related Macular Degeneration

Innovent Reports First Patient Dosing in P-II Trial of IBI302 for Neovascular Age-Related Macular Degeneration

April 30, 2021

FibroGen Report Enrollment of First Patient in P-II Study Evaluating Pamrevlumab in Patients Hospitalized with Acute COVID-19

FibroGen Report Enrollment of First Patient in P-II Study Evaluating Pamrevlumab in Patients Hospitalized with Acute COVID-19

June 24, 2020

Theravance Reports First Patient Dosing in P-I Study with TD-0903 to Treat Patients with Acute Lung Injury Associated with COVID-19

Theravance Reports First Patient Dosing in P-I Study with TD-0903 to Treat Patients with Acute Lung Injury Associated with COVID-1...

April 23, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us